CPC A61K 31/736 (2013.01) [A61K 9/0048 (2013.01); A61K 31/728 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/36 (2013.01)] | 12 Claims |
1. An ophthalmic composition comprising 0.1 to 0.2 w/v % hydroxylpropyl guar, 0.13 to 0.17 w/v % hyaluronic acid, 1.0 to 2.0 w/v % cis-diol and a pharmaceutically active compound, wherein the cis-diol is sorbitol and the pharmaceutically active compound is selected from the group consisting of a glaucoma therapeutic, a pain reliever, an anti-inflammatory medication, an anti-allergy medication, a post- surgical antihypertensive agent, a dry eye therapeutic, an anti-infective, and an anti-microbial, for the treatment of ophthalmic diseases.
|